Siblings 會議論文/會議摘要 [6/8] 報告 [0/1] 專利 [0/10] Collection Statistics 近3年內發表的文件:1(2.17%) 含全文筆數:46(100.00%) 文件下載次數統計 下載大於0次:46(100.00%) 下載大於100次:46(100.00%) 檔案下載總次數:35617(90.60%) 最後更新時間: 2024-12-01 11:34 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 Discovery and development of a nove... Xanthine derivatives reveal an allo... Unique sulfur-aromatic interactions... Identification of a multitargeted t... Discovery of a furanopyrimidine-bas... Discovery of Conformational Control... 4-Bromophenylhydrazinyl benzenesulf... Mutagenesis of dengue virus protein... Pyrazolylamine derivatives reveal t... Phenyl benzenesulfonylhydrazides ex...

跳至: (選擇年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目26-46 / 46. (共2頁) << < 1 2  每頁顯示[10|25|50]項目

日期	題名	關聯
2010-03-11	5-Amino-2-Aroylquinolines as Highly Potent Tubulin Polymerization Inhibitors	Journal of Medicinal Chemistry. 2010 Mar 11;53(5):2309-2313.
2010-02-01	Identification, SAR studies, and X-ray Co-crystallographic analysis of a novel furanopyrimidine aurora kinase a inhibitor	ChemMedChem. 2010 Feb 1;5(2):255-267.
2009-10	(1,3-Diphenyl-1H-pyrazol-4-yl)-methylamine analogues as inhibitors of dipeptidyl peptidases	Journal of the Chinese Chemical Society. 2009 Oct;56(5):1048-1055.
2009-08-13	Synthesis and evaluation of 3-aroylindoles as anticancer agents: Metabolite approach	Journal of Medicinal Chemistry. 2009 Aug 13;52(15):4941-4945.
2009-07-23	Generation of ligand-based pharmacophore model and virtual screening for identification of novel tubulin inhibitors with potent anticancer activity	Journal of Medicinal Chemistry. 2009 Jul 23;52(14):4221-4233.
2009-06	A three-dimensional pharmacophore model for dipeptidyl peptidase IV inhibitiors [Erratum: European Journal of Medicinal Chemistry. 2008 Aug;43(8):1603-1611.]	European Journal of Medicinal Chemistry. 2009 Jun;44(6):2763-2763.
2009-04-23	Design and structural analysis of novel pharmacophores for potent and selective peroxisome proliferator-activated receptor gamma agonists	Journal of Medicinal Chemistry. 2009 Apr 23;52(8):2618-2622.
2009-02-26	Structure-based drug design of novel aurora kinase a inhibitors: Structural basis for potency and specificity	Journal of Medicinal Chemistry. 2009 Feb 26;52(4):1050-1062.
2008-12-25	Synthesis and structure-activity relationships of 2-amino-1-aroylnaphthalene and 2-hydroxy-1-aroylnaphthalenes as potent antitubulin agents	Journal of Medicinal Chemistry. 2008 Dec 25;51(24):8163-8167.
2008-08	A three-dimensional pharmacophore model for dipeptidyl peptidase IV inhibitors	European Journal of Medicinal Chemistry. 2008 Aug;43(8):1603-1611.
2008-03-01	Aurora kinase A inhibitors: Identification, SAR exploration and molecular modeling of 6,7-dihydro-4H-pyrazolo-[1,5-a]pyrrolo[3,4-d]pyrimidine-5,8-dione scaffold	Bioorganic and Medicinal Chemistry Letters. 2008 Mar;18(5):1623-1627.
2008	Structure-based inhibitors exhibit differential activities against Helicobacter pylori and Escherichia coli undecaprenyl pyrophosphate synthases	Journal of Biomedicine and Biotechnology. 2008; 2008:Article number 841312.
2006-10-19	Structural basis for the structure-activity relationships of peroxisome proliferator-activated receptor agonists	Journal of Medicinal Chemistry. 2006 Oct;49(21):6421-6424.
2006-08-24	Structure-based drug design and structural biology study of novel nonpeptide inhibitors of severe acute respiratory syndrome coronavirus main protease	Journal of Medicinal Chemistry. 2006 Aug;49(17):5154-5161.
2006-06-15	Discovery of a novel family of SARS-CoV protease inhibitors by virtual screening and 3D-QSAR studies	Journal of Medicinal Chemistry. 2006 Jun;49(12):3485-3495.
2006-05-04	Structure-based drug design of a novel family of PPAR gamma partial agonists: Virtual screening, X-ray crystallography, and in vitro/in vivo biological activities	Journal of Medicinal Chemistry. 2006 May;49(9):2703-2712.
2006-02-09	Indol-1-yl acetic acids as peroxisome proliferator-activated receptor agonists: Design, synthesis, structural biology, and molecular docking studies	Journal of Medicinal Chemistry. 2006 Feb;49(3):1212-1216.
2006-01-12	2-[3-[2-[(2S)-2-cyano-1-pyrrolidinyl]-2-oxoethylamino]-3-methyl-1-oxobutyl]-1,2,3,4-tetrahydroisoquinoline: A potent, selective, and orally bioavailable dipeptide-derived inhibitor of dipeptidyl peptidase IV	Journal of Medicinal Chemistry. 2006 Jan;49(1):373-380.
2005-12-29	Novel indole-based peroxisome proliferator-activated receptor agonists: Design, SAR, structural biology, and biological activities	Journal of Medicinal Chemistry. 2005 Dec;48(26):8194-8208.
2005-12-15	The effect of N-terminal truncation on double-dimer assembly of goose delta-crystallin	Biochemical Journal. 2005 Dec;392(Pt. 3):545-554.
2005-07-01	Glutamic acid analogues as potent dipeptidyl peptidase IV and 8 inhibitors	Bioorganic and Medicinal Chemistry Letters. 2005 Jul;15(13):3271-3275.

顯示項目26-46 / 46. (共2頁) << < 1 2  每頁顯示[10|25|50]項目